Utility of solar-powered oxygen delivery in a resource-constrained setting.

Area of Science:

• Global Health
• Pediatric Critical Care
• Biomedical Engineering

Background:

• Pneumonia is a major global cause of child mortality.
• Severe pneumonia requires oxygen therapy, which is often unavailable in resource-constrained settings.
• Solar-powered oxygen (SPO2) offers a sustainable solution for oxygen delivery in these areas.

Purpose of the Study:

• To evaluate if introducing solar-powered oxygen (SPO2) reduces mortality in children with hypoxemic respiratory illness.
• To compare mortality rates before and after SPO2 implementation in resource-limited hospitals.

Main Methods:

• A pragmatic, quasi-experimental study design was employed.
• Compared mortality in children under 5 with hypoxemic respiratory illness before and after SPO2 installation.
• Primary outcome: 30-day mortality. Secondary outcomes: in-hospital mortality, length of stay, duration of oxygen therapy, and system failures.

Main Results:

• Mortality decreased from 60% pre-SPO2 to 30% post-SPO2, a 50% relative risk reduction (p=0.0049).
• Statistical models confirmed decreased mortality post-SPO2, even after adjusting for confounders.
• Survival curves showed a significant improvement post-SPO2 (HR 0.39, p=0.0043), linked to fewer oxygen supply interruptions.

Conclusions:

• Solar-powered oxygen (SPO2) installation is associated with reduced mortality in pediatric patients in resource-constrained settings.
• SPO2 effectively addresses oxygen supply challenges, improving patient outcomes.
• This technology presents a viable and impactful intervention for improving child survival globally.